RE: patent : composition and method27 Oct 2021 22:23
@byp if some of that is directed at me well my average is a good bit below £3, I'm not deep underwater or desperate or any of those things - granted I've moved a serious amount of money in again at £2.50 to get the average this low...
I thought I was out for good earlier in the year and was happy with the profits I'd made, albeit much reduced on what they were at one point, but I simply believe the risk vs reward is asymmetrical now. I believe we are only so low because the previous administration (namely Graham) made some big mistakes / didn't care much for shareholder engagement and now we are being punished once again for not seeing an immediate change in communications from the new man in charge.
There are lots of unknowns and risks ahead but I still feel way more comfortable having all this money in a small cap with no financial constraints (EKF have £20m cash available for example), no risk of a placing and are perfectly placed to take advantage of the increased spending going into diagnostics post pandemic.
So no not all of us are in because we won't sell at a loss, many of us think this company at this price is as good value as it gets.